---All---
  • ---All---
  • Accession
  • Catalog #

ADK Antibody (C-term) Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP7091b 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

ADK Antibody (C-term) Blocking Peptide - Product info

Primary AccessionP55263
Other AccessionNP_006712
Clone Names4011904
Calculated MW40545 Da

ADK Antibody (C-term) Blocking Peptide - Additional info

Gene ID 132
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP7091b was selected from the C-term region of human ADK . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

ADK Antibody (C-term) Blocking Peptide - Protein Information

Name ADK
Function
ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides
Tissue Location
Widely expressed. Highest level in placenta, liver, muscle and kidney

ADK Antibody (C-term) Blocking Peptide - Related products

AP7091a: ADK Antibody (N-term)

AP7091b: ADK Antibody (C-term)

RI10146: ADK predesign siRNA

LY10132a: ADK Over-expression Lysate

BP7091a: ADK Antibody (N-term) Blocking Peptide

BP7091b: ADK Antibody (C-term) Blocking Peptide

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Adenosine kinase is an abundant enzyme in mammalian tissues. The enzyme catalyzes the transfer of the gamma-phosphate from ATP to adenosine, thereby serving as a regulator of concentrations of both extracellular adenosine and intracellular adenine nucleotides. Adenosine has widespread effects on the cardiovascular, nervous, respiratory, and immune systems and inhibitors of the enzyme could play an important pharmacological role in increasing intravascular adenosine concentrations and acting as anti-inflammatory agents. Alternative splicing results in two transcript variants encoding different isoforms. Both isoforms of the enzyme phosphorylate adenosine with identical kinetics and both require Mg2+ for activity.

REFERENCES

Szkotak, A.J., et al., J. Membr. Biol. 192(3):169-179 (2003).Singh, B., et al., DNA Cell Biol. 20(1):53-65 (2001).Van Rompay, A.R., et al., Eur. J. Biochem. 261(2):509-517 (1999).Mathews, I.I., et al., Biochemistry 37(45):15607-15620 (1998).McNally, T., et al., Biochem. Biophys. Res. Commun. 231(3):645-650 (1997).